India medical device regulatory intelligence, Week 16, 2026.

Signals from 2026-04-13 to 2026-04-19, covering safety alerts, regulatory changes, device registrations, market movement, and source activity for India.

Signals
28
Sources
2
Index status
Indexable
EXECUTIVE SUMMARY

India generated 28 qualifying medical device signals during Week 16, 2026. Safety alerts led the week with 27 signals, while FDA Device Enforcement was the most active source. LAI-PrEP testing strategies show similar HIV detection rates but RDTs offer faster results and lower costs. Philips recalls ALLURA Xper FD20 OR Table due to intermittent X-ray imaging issues with the foot switch.

Key observations

Safety alerts accounted for 27 of 28 qualifying signals, making it the main review lane for the week.
Market signals formed the second-largest cluster, which is useful context for teams separating safety work from regulatory and market monitoring.
FDA Device Enforcement contributed 27 signals, so source-level follow-up should start there.
Burlington appeared repeatedly in the highlighted signals, which may warrant closer product, manufacturer, or competitor tracking.

Category interpretation

Safety alerts

27 safety alerts appeared in India during Week 16, 2026. Safety concentration usually matters to quality, vigilance, and post-market surveillance teams because it can reveal emerging field risks.

Market signals

1 market signals appeared in India during Week 16, 2026. Market signals help connect regulatory monitoring with launch planning, reimbursement, and commercial strategy.

Recommended monitoring focus

  • Review CDSCO safety and recall activity for product categories that overlap your portfolio.
  • Use market trend signals to brief commercial, strategy, and market access teams alongside regulatory stakeholders.
  • Maintain weekly monitoring for India, especially when low-volume weeks precede regulator database updates.
  • Validate high-impact items against the original source before using them in quality or regulatory decision-making.
  • Compare this week with the next completed week to separate one-off noise from sustained category movement.

Source-backed signal evidence

These source-linked items support the weekly analysis above. They are included for verification and follow-up, not as a raw feed export.

PLOS Medicine·Market signals·

Rapid diagnostic tests, laboratory-based immunoassay and nucleic acid testing strategies for long-acting injectable pre-exposure prophylaxis: A systematic review

LAI-PrEP testing strategies show similar HIV detection rates but RDTs offer faster results and lower costs.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: ALLURA Xper FD20 OR Table; System Code: (1) 722015, (2)722023, (3)722035; (PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.)

Philips recalls ALLURA Xper FD20 OR Table due to intermittent X-ray imaging issues with the foot switch.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Burlington Medical, Protective Sleeves. (Burlington Medical, LLC)

Burlington Medical recalls Class II protective sleeves due to potential lifespan degradation.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Paradigm Insulin Pump (MMT-712, MMT-715) (Medtronic MiniMed, Inc.)

Medtronic MiniMed's Paradigm Insulin Pumps are recalled due to risks of insulin over- and under-delivery affecting patient safety.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Burlington Medical, Kilt Blockers. (Burlington Medical, LLC)

Burlington Medical's Kilt Blockers recalled due to potential lifespan degradation, affecting worldwide distribution.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Burlington Medical, Demi Half Aprons. (Burlington Medical, LLC)

Burlington Medical recalls Class II Demi Half Aprons due to potential attenuation degradation affecting lifespan.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Azurion 5 M12; System Code: (1)722227, (2)722231; (PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.)

Philips recalled Azurion 5 M12 due to intermittent X-ray imaging issues with the wired foot switch.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Atellica CH Enzymatic Hemoglobin A1c (A1c_E); Siemens Material Number (SMN): 11097536; (Siemens Healthcare Diagnostics, Inc.)

Siemens recalls Atellica CH A1c_E due to potential negative bias affecting diabetes diagnosis.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Burlington Medical, Vest (Burlington Medical, LLC)

Burlington Medical recalled its Class II vest due to potential attenuation degradation affecting lifespan.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Burlington Medical, Half Aprons. (Burlington Medical, LLC)

Burlington Medical recalls Class II Half Aprons due to potential attenuation degradation affecting lifespan.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: MiniMed 620G Insulin Pump (MMT-1750) (Medtronic MiniMed, Inc.)

Medtronic's MiniMed 620G insulin pump recalled due to risks of insulin over- and under-delivery affecting patient safety.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Burlington Medical, Leg Wraps. (Burlington Medical, LLC)

Burlington Medical recalls Class II leg wraps due to potential lifespan degradation.

Source

Safety alerts

FDA Device Enforcement·Safety alerts·

Enforcement Class II: ALLURA Xper FD20 OR Table; System Code: (1) 722015, (2)722023, (3)722035; (PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.)

Philips recalls ALLURA Xper FD20 OR Table due to intermittent X-ray imaging issues with the foot switch.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Burlington Medical, Protective Sleeves. (Burlington Medical, LLC)

Burlington Medical recalls Class II protective sleeves due to potential lifespan degradation.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Paradigm Insulin Pump (MMT-712, MMT-715) (Medtronic MiniMed, Inc.)

Medtronic MiniMed's Paradigm Insulin Pumps are recalled due to risks of insulin over- and under-delivery affecting patient safety.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Burlington Medical, Kilt Blockers. (Burlington Medical, LLC)

Burlington Medical's Kilt Blockers recalled due to potential lifespan degradation, affecting worldwide distribution.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Burlington Medical, Demi Half Aprons. (Burlington Medical, LLC)

Burlington Medical recalls Class II Demi Half Aprons due to potential attenuation degradation affecting lifespan.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Azurion 5 M12; System Code: (1)722227, (2)722231; (PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.)

Philips recalled Azurion 5 M12 due to intermittent X-ray imaging issues with the wired foot switch.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Atellica CH Enzymatic Hemoglobin A1c (A1c_E); Siemens Material Number (SMN): 11097536; (Siemens Healthcare Diagnostics, Inc.)

Siemens recalls Atellica CH A1c_E due to potential negative bias affecting diabetes diagnosis.

Source
FDA Device Enforcement·Safety alerts·

Enforcement Class II: Burlington Medical, Vest (Burlington Medical, LLC)

Burlington Medical recalled its Class II vest due to potential attenuation degradation affecting lifespan.

Source

Market signals

PLOS Medicine·Market signals·

Rapid diagnostic tests, laboratory-based immunoassay and nucleic acid testing strategies for long-acting injectable pre-exposure prophylaxis: A systematic review

LAI-PrEP testing strategies show similar HIV detection rates but RDTs offer faster results and lower costs.

Source

Track these signals continuously.

MedFlux monitors regulators and medical device market sources across priority countries so regulatory, quality, and strategy teams can review changes without manually checking agency databases.

Related MedFlux intelligence pages